
The University of Birmingham has developed a state-of-the-art GMP Manufacturing Suite for Advanced Therapies development.
Licensed by the MHRA for the manufacture of Advanced Therapy Medicinal Products (ATMP) for clinical use, experts within the Advanced Therapies Facility (ATF) also benefit from a Specials licence allowing the manufacture of products for use in selected patients outside of clinical trial settings. The ATF is situated adjacent to the NIHR/Wellcome Trust Clinical Research Facility, where manufactured products can be administered to patients in an appropriate clinical environment.
Through collaborative research with partners and clients the Facility strives to further the development of effective cell-, tissue- and gene-based therapies, in a predominantly clinical trial environment.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.